2021 Predictions for Regenerative Medicine as the Pandemic Continues
January 29, 2021
While the pandemic continues to disrupt many industries, including regenerative medicine, it’s not all bad news -- in fact, there are likely some bright spotsahead for the industry this year.
In an article featured on Technology Network, Cryoport Systems CEO Mark Sawicki, Ph.D. predicts initial expectations for the regenerative medicine space in 2021. Sawicki outlines the clinical trial impact for cell and gene therapies, COVID-19's impact on vaccine development and cell and gene therapy distribution, and commercial activity and regulatory considerations within regenerative medicine.